Abstract
Background and Aims: Cardiovascular disease (CVD) is the major cause of mortality among chronic kidney disease (CKD) patients where the reductions in serum Klotho have been related with a better prognose. However, it is unclear whether circulating Klotho, and its expression in peripheral blood cells (PBCs), are associated with subclinical atherosclerotic cardiovascular disease (sCVD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
